Article V: Clinically important errors in data interpretation

Journal of the American Veterinary Medical Association

Volumn 213, Issue 11, 1998, Pages 1564-1569

  Martinez, Marilyn N ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VETERINARY DRUG;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; DOSE RESPONSE; HALF LIFE TIME; METABOLIC CLEARANCE RATE; STATISTICAL ANALYSIS; TIME; TISSUE DISTRIBUTION;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HALF-LIFE; METABOLIC CLEARANCE RATE; TIME FACTORS; TISSUE DISTRIBUTION; VETERINARY DRUGS;

EID: 0032420056     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Martinez MN, Riviere JE, Koritz GD. Review of the first interactive workshop on professional flexible labeling. J Am Vet Med Assoc 1995;207:865-913.
2. Martinez MN, Brown SA, Copeland DD, et al. Professional Flexible Labeling Workshop II Task Force Report: developing a model of a professional veterinary drug label. J Am Vet Med Assoc 1996;209:83-91.
3. Gibaldi M, Perrier D. Pharmacokinetics. New York: Marcel Dekker Inc, 1982.
4. Ludden TM. Nonlinear pharmacokinetics: clinical implications. Clin Pharm 1991;20:429-446.
5. Perrier D, Ashley JJ, Levy G. Effect of product inhibition of kinetics of drug elimination. J Pharm Biopharm 1973;1:231-242.
6. Martinez MN, Berson MR. Bioavailability/bioequivalence assessments. In: Hardy G, Baggot JD, eds. The development of veterinary dosage forms. New York: Marcel Dekker Inc, 1998.
7. Riviere JE. Pharmacologic principles of residue avoidance for veterinary practitioners. J Am Vet Med Assoc 1991;198:809-819.
8. Shargel L, Yu ABC. Applied biopharmaceutics and pharmacokinetics. 3rd ed. Norwalk, Conn: Appleton & Lange Publishers, 1993.
9. Martinez MN. Article II: Volume, clearance, and hall-life. J Am Vet Med Assoc 1998;213:1122-1127.
10. Koritz GD. Human food safety considerations. J Vet Pharmacol Ther 1994;17:113-115.
11. Martinez MN. Article I: Noncompartmental methods of drug characterization: statistical moment theory. J Am Vet Med Assoc 1998;213:974-980.
12. Martinez MN, Jackson AJ. Suitability of various noninfinity area under the plasma concentration-time curve (AUC) estimates for use in bioequivalence determinations: relationship to AUC from zero to time infinity (AUC0-INF). Pharmacol Res 1991;8:512-517.
13. Lovering EG, McGilveray IJ, McMillan I, et al. Comparative biovailability from truncated blood level curves. J Pharm Sci 1975;64:1521-1524.
14. Bois FY, Tozer TN, Hauck WW, et al. Bioequivalence: performance of several measures of extent of absorption. Pharmacol Res 1994;11:715-722.
15. Hennessy DR, Steel JW, Prichard RK. Biliary secretion and enterohepatic recycling of fenbendazole metabolites in sheep. J Vet Pharmacol Ther 1993;16:132-140.
16. Martinez MN. Article III: Physicochemical properties of pharmaceuticals. J Am Vet Med Assoc 1998;213:1274-1277.
17. Shepard TA, Gannaway DJ, Lockwood GF. Accumulation and time to steady-state for drugs subject to enterohepatic cycling: a simulation study. J Pharm Sci 1985;74:331-333.
18. Pollack GM, Brouwer KL. Physiologic and metabolic influences on enterohepatic recirculation: simulations based upon the disposition of valproic acid in the rat. J Pharmacokinet Biopharm 1991;19:189-225.
19. Shepard TA, Gannaway DJ, Lockwood GF. Accumulation and time to steady state for drugs subject to enterophepatic cycling: a simulation study. J Pharm Sci 1985;74:1331-1333.
20. Ronfeld RA, Benet LZ. Interpretation of plasma concentration-time curves after oral dosing. J Pharm Sci 1977;66:178-180.
21. Riviere JE, Craigmill AL, Sundlof SF. Handbook of comparative pharmacokinetics and residues of veterinary antimicrobials. Boca Raton, Fla: CRC Press, 1991.
22. Craigmill AL, Sundlof SF, Riviere JE. Handbook of comparative pharmacokinetics and residues of veterinary therapeutic drugs. Boca Raton, Fla: CRC Press, 1994.